Dr Harry Paul Erba shares his perspectives on the evolving therapeutic landscape for patients with leukemia and myelodysplastic syndromes, moderated by Dr Stephen &quot;Fred&quot; Divers. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/AON24" rel="nofollow">here</a>.

<description>Dr Harry Paul Erba shares his perspectives on the evolving therapeutic landscape for patients with leukemia and myelodysplastic syndromes, moderated by Dr Stephen "Fred" Divers. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/AON24). 
</description>

Featuring a discussion with Dr Harry Paul Erba on the current management of and promising approaches for leukemia and myelodysplastic syndromes, moderated by Dr Stephen "Fred" Divers. Produced by Research To Practice. 

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer, moderated by Dr Stephen “Fred” Divers. Produced by Research To Practice. 

CME information and select publications here.

<description>Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer, moderated by Dr Stephen “Fred” Divers. Produced by Research To Practice. 
CME information and select publications here. 
</description>

Featuring a discussion with Dr Edward B Garon on the current optimal management of and promising investigational approaches for lung cancer, moderated by Dr Stephen “Fred” Divers. Produced by Research To Practice. 

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/5MJC2024/OralSERDsmBC/2" rel="nofollow">here</a>.

<description>Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/5MJC2024/OralSERDsmBC/2). 
</description>

Featuring a discussion on the use of oral SERDs in the treatment of breast cancer with Dr Seth Wander, moderated by Dr Neil Love. Produced by Research To Practice. 

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

Dr Heather Wakelee from Stanford University School of Medicine in California discusses the implications of recent datasets for the current and future use of nontargeted therapy for metastatic non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/MTPWLE24" rel="nofollow">here</a>.

<description>Dr Heather Wakelee from Stanford University School of Medicine in California discusses the implications of recent datasets for the current and future use of nontargeted therapy for metastatic non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/MTPWLE24). 
</description>

Featuring a discussion of recent datasets for the use of nontargeted therapy for metastatic non-small cell lung cancer with Dr Heather Wakelee, moderated by Dr Neil Love. Produced by Research To Practice. 

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood and Dr Sara M Tolaney from Dana-Farber Cancer Center in Boston discuss recent updates on available and novel treatment strategies for metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. 

CME information and select publications <a href="https://www.researchtopractice.com/FCS2024mTNBC" rel="nofollow">here</a>.

<description>Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood and Dr Sara M Tolaney from Dana-Farber Cancer Center in Boston discuss recent updates on available and novel treatment strategies for metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. 
CME information and select publications here (https://www.researchtopractice.com/FCS2024mTNBC). 
</description>

Featuring a discussion on the optimal management of metastatic triple-negative breast cancer with Drs Priyanka Sharma and Sara M Tolaney, moderated by Dr Neil Love. Produced by Research To Practice. 

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer 

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.


Head & Neck Cancer Update

Details

Recent Episodes